John C. Bolger - Mar 1, 2022 Form 4 Insider Report for Fulgent Genetics, Inc. (FLGT)

Role
Director
Signature
/s/ Paul Kim, as Attorney-in-fact
Stock symbol
FLGT
Transactions as of
Mar 1, 2022
Transactions value $
-$99,085
Form type
4
Date filed
3/3/2022, 04:01 PM
Previous filing
Sep 1, 2021
Next filing
May 20, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FLGT Common Stock Options Exercise $2.45K +625 +31.25% $3.93* 2.63K Mar 1, 2022 Direct
transaction FLGT Common Stock Sale -$38.4K -625 -23.81% $61.42 2K Mar 1, 2022 Direct F1
transaction FLGT Common Stock Options Exercise $3.63K +625 +31.25% $5.81* 2.63K Mar 1, 2022 Direct
transaction FLGT Common Stock Sale -$38.4K -625 -23.81% $61.40 2K Mar 1, 2022 Direct
transaction FLGT Common Stock Options Exercise $9.89K +625 +31.25% $15.82 2.63K Mar 1, 2022 Direct
transaction FLGT Common Stock Sale -$38.3K -625 -23.81% $61.27 2K Mar 1, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FLGT Stock Option (Right to Buy) Options Exercise $0 -625 -66.63% $0.00 313 Mar 1, 2022 Common Stock 625 $3.93 Direct F2
transaction FLGT Stock Option (Right to Buy) Options Exercise $0 -625 -28.56% $0.00 1.56K Mar 1, 2022 Common Stock 625 $5.81 Direct F3
transaction FLGT Stock Option (Right to Buy) Options Exercise $0 -625 -18.18% $0.00 2.81K Mar 1, 2022 Common Stock 625 $15.82 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were sold in multiple transactions at prices ranging from $61.0767 to $61.4400, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
F2 The shares subject to the option vest over a period of four years, with 1/4th of such units vesting 12 months after May 18 2018, and 1/16th of such shares vesting at the end of every three-month period over the 36 months thereafter, subject to the reporting person's continued service for the Issuer on each vesting date.
F3 The shares subject to the option vest over a period of four years, with 1/4th of such units vesting 12 months after May 30, 2019, and 1/16th of such shares vesting at the end of every three-month period over the 36 months thereafter, subject to the reporting person's continued service for the Issuer on each vesting date.
F4 The shares subject to the option vest over a period of four years, with 1/4th of such units vesting 12 months after May 27, 2020, and 1/16th of such shares vesting at the end of every three-month period over the 36 months thereafter, subject to the reporting person's continued service for the Issuer on each vesting date.